|Articles|July 21, 2003
FDA and industry puzzle over drug-name fixes
FDA and industry hold public meeting on the issue of drug names and drug errors.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Cigna to Remedy Years of Unfair Business Practices with Patients and Pharmacies
2
FDA Reaffirms Strict Regulations Amid GLP-1 Compounding Concerns
3
GLP-1 Receptor Agonists Show Potential as Tools Against Chronic Inflammation in Diabetes
4
OTC Products: Smoking Cessation
5
































